Nanostream Streamlines HPLC

Because traditional HPLC is slow, high-throughput drug discovery often hits a bottleneck when large numbers of reaction products are assayed. This bottleneck can be eased by techniques such as microparallel liquid chromatography (μPLC), in which samples are assayed in parallel using microfluidic technology.But moving liquids through tiny tubes poses special challenges, too, such as troubleshooting for tiny leaks. In Pasadena, Calif.-based Nanostream's Veloce system, these challenges are ove

Written bySteve Buckingham
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Because traditional HPLC is slow, high-throughput drug discovery often hits a bottleneck when large numbers of reaction products are assayed. This bottleneck can be eased by techniques such as microparallel liquid chromatography (μPLC), in which samples are assayed in parallel using microfluidic technology.

But moving liquids through tiny tubes poses special challenges, too, such as troubleshooting for tiny leaks. In Pasadena, Calif.-based Nanostream's Veloce system, these challenges are overcome by using ready-made, plug-in cartridges with all the microplumbing preinstalled, including the HPLC columns http://www.nanostream.com. Nanostream recently upgraded its Brio cartridge line to further speed up the process.

Each Brio cartridge incorporates 24 HPLC columns packed with standard (C18) stationary-phase material. The new cartridges sport shorter columns (3 cm instead of the original 8 cm), accelerating the separation process. Using the system's eight-head autosampler, Nanostream claims that analysis times can be as little as 15 seconds per sample.

"Veloce has generated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies